Changes in mGlu5 Receptor-Dependent Synaptic Plasticity and Coupling to Homer Proteins in the Hippocampus of Ube3A Hemizygous Mice Modeling Angelman Syndrome
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Angelman syndrome (AS) is caused by the loss of Ube3A, an ubiquitin ligase that commits specific proteins to proteasomal degradation. How this defect causes autism and other pathological phenotypes associated with AS is unknown. Long-term depression (LTD) of excitatory synaptic transmission mediated by type 5 metabotropic glutamate (mGlu5) receptors was enhanced in hippocampal slices of Ube3A m−/p+mice, which model AS. No changes were found in NMDA-dependent LTD induced by low-frequency stimulation. mGlu5 receptor-dependent LTD in AS mice was sensitive to the protein synthesis inhibitor anisomycin, and relied on the same signaling pathways as in wild-type mice, e.g., the mitogen-activated protein kinase (MAPK) pathway, the phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycine pathway, and protein tyrosine phosphatase. Neither the stimulation of MAPK and PI3K nor the increase in Arc (activity-regulated cytoskeleton-associated protein) levels in response to mGlu5 receptor activation were abnormal in hippocampal slices from AS mice compared with wild-type mice. mGlu5 receptor expression and mGlu1/5 receptor-mediated polyphosphoinositide hydrolysis were also unchanged in the hippocampus of AS mice. In contrast, AS mice showed a reduced expression of the short Homer protein isoform Homer 1a, and an increased coupling of mGlu5 receptors to Homer 1b/c proteins in the hippocampus. These findings support the link between Homer proteins and monogenic autism, and lay the groundwork for the use of mGlu5 receptor antagonists in AS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · cited 2×
“…mediated by type 5 metabotropic glutamate (mGlu5) receptors is amplified in the hippocampus of Fmr1 knock-out mice modeling fragile X syndrome (FXS; Huber et al., 2002; Bear et al., 2004), a genetic disorder associated with autism in 30 –35% of affected children (Kelleher and Bear, 2008).”
BackgroundAltered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · cited 3×
“…mediated by type 5 metabotropic glutamate (mGlu5) receptors is amplified in the hippocampus of Fmr1 knock-out mice modeling fragile X syndrome (FXS; Huber et al., 2002; Bear et al., 2004), a genetic disorder associated with autism in 30 –35% of affected children (Kelleher and Bear, 2008).”
BackgroundCorrection of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977
Long-term depression in the CNS
Collingridge, G. L., Peineau, S., Howland, J. G., & Wang, Y. T. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2867 · Cited by 926 · cited 3×
“Using specific pharmacological inhibitors, we showed that mGlu5 receptor-dependent LTD in AS mice relied on the same signaling pathways that mediate LTD in wild-type mice, i.e., the PTP, MAPK, and PI3K/ mTOR pathways (Gladding et al., 2009; Collingridge et al., 2010; Lüscher and Huber, 2010).”
BackgroundTu, J. C., Xiao, B., Yuan, J. P., Lanahan, A. A., Leoffert, K., Li, M., Linden, D. J., & Worley, P. F. (1998) · Neuron · doi:10.1016/s0896-6273(00)80589-9 · Cited by 862 · cited 3×
“Interaction between mGlu5 receptors and Homer proteins (Tu et al., 1998; Xiao et al., 1998) has been implicated in LTD induction (Ronesi and Huber, 2008; Takayasu et al.”
BackgroundJiang, Y.-H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D., & Beaudet, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80596-6 · Cited by 852 · cited 4×
“AS mice did not show alterations in basal synaptic transmission (Fig. 1B; p 0.05; Jiang et al., 1998), and in LTD induced by low-frequency stimulation, which is known to be dependent on NMDA receptor activation (for review, see Manabe, 1997).”
BackgroundInfluentialLüscher, C., & Huber, K. M. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.016 · Cited by 627 · cited 2×
“Using specific pharmacological inhibitors, we showed that mGlu5 receptor-dependent LTD in AS mice relied on the same signaling pathways that mediate LTD in wild-type mice, i.e., the PTP, MAPK, and PI3K/ mTOR pathways (Gladding et al., 2009; Collingridge et al., 2010; Lüscher and Huber, 2010).”
BackgroundThe Autistic Neuron: Troubled Translation?
Kelleher, R. J., & Bear, M. F. (2008) · Cell · doi:10.1016/j.cell.2008.10.017 · Cited by 598 · cited 2×
“…mediated by type 5 metabotropic glutamate (mGlu5) receptors is amplified in the hippocampus of Fmr1 knock-out mice modeling fragile X syndrome (FXS; Huber et al., 2002; Bear et al., 2004), a genetic disorder associated with autism in 30 –35% of affected children (Kelleher and Bear, 2008).”
BackgroundMutations causing syndromic autism define an axis of synaptic pathophysiology
Auerbach, B. D., Osterweil, E. K., & Bear, M. F. (2011) · Nature · doi:10.1038/nature10658 · Cited by 592
Hou, L., & Klann, E. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0995-04.2004 · Cited by 527 · cited 1×
“1G; for data with MPEP in normal mice, see Faas et al., 2002; Hou and Klann, 2004; Volk et al., 2006).”
BackgroundPark, S., Park, J. M., Kim, S., Kim, J.-A., Shepherd, J. D., Smith-Hicks, C. L., Chowdhury, S., Kaufmann, W., Kuhl, D., Ryazanov, A. G., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.023 · Cited by 516 · cited 1×
“We measured the expression of Arc, the product of an early inducible gene that has been implicated in mechanisms of mGlu5 receptor-dependent LTD (Park et al., 2008; Waung et al., 2008).”
BackgroundChronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
Michalon, A., Sidorov, M., Ballard, T. M., Ozmen, L., Spooren, W., Wettstein, J. G., Jaeschke, G., Bear, M. F., & Lindemann, L. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.009 · Cited by 489
Waung, M. W., Pfeiffer, B. E., Nosyreva, E. D., Ronesi, J. A., & Huber, K. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.014 · Cited by 474 · cited 1×
“We measured the expression of Arc, the product of an early inducible gene that has been implicated in mechanisms of mGlu5 receptor-dependent LTD (Park et al., 2008; Waung et al., 2008).”
BackgroundHou, L., Antion, M. D., Hu, D., Spencer, C. M., Paylor, R., & Klann, E. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.005 · Cited by 469 · cited 1×
“In FXS mice, LTD is enhanced and becomes independent of new protein synthesis because of the lack of FMRP, which normally restrains translation of LTD-related proteins (Huber et al., 2002; Hou et al., 2006; Nosyreva and Huber, 2006).”
BackgroundThe Pathophysiology of Fragile X (and What It Teaches Us about Synapses)
Bhakar, A. L., Dölen, G., & Bear, M. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153138 · Cited by 370 · cited 2×
“…that reduce the expression of mGlu5 receptors (Dölen et al., 2007) or by treatments with negative allosteric modulators (NAMs) of mGlu5 receptors (Bhakar et al., 2012; Michalon et al., 2012), suggesting that exaggerated mGlu5 receptor activity contributes to the pathophysiology of FXS. Moving…”
BackgroundTranslational Suppression by Trinucleotide Repeat Expansion at FMR1
Feng, Y., Zhang, F., Lokey, L. K., Chastain, J. L., Lakkis, L., Eberhart, D., & Warren, S. T. (1995) · Science · doi:10.1126/science.7732383 · Cited by 358
Ube3a is required for experience-dependent maturation of the neocortex
Yashiro, K., Riday, T. T., Condon, K. H., Roberts, A. C., Bernardo, D. R., Prakash, R., Weinberg, R. J., Ehlers, M. D., & Philpot, B. D. (2009) · Nature Neuroscience · doi:10.1038/nn.2327 · Cited by 328
Toward Fulfilling the Promise of Molecular Medicine in Fragile X Syndrome
Krueger, D. D., & Bear, M. F. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-061109-134644 · Cited by 259 · cited 1×
“…2012), suggesting that exaggerated mGlu5 receptor activity contributes to the pathophysiology of FXS. Moving from these findings, clinical studies are underway to test the effectiveness of mGlu5 receptor NAMs in the treatment of FXS (for review, see Krueger and Bear, 2011; Hagerman et al., 2012).”
BackgroundDisrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome
Ronesi, J. A., Collins, K. A., Hays, S. A., Tsai, N.-P., Guo, W., Birnbaum, S. G., Hu, J.-H., Worley, P. F., Gibson, J. R., & Huber, K. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3033 · Cited by 251
Metabotropic Glutamate Receptor-Mediated Long-Term Depression: Molecular Mechanisms
Gladding, C. M., Fitzjohn, S. M., & Molnár, E. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001735 · Cited by 233 · cited 2×
“Using specific pharmacological inhibitors, we showed that mGlu5 receptor-dependent LTD in AS mice relied on the same signaling pathways that mediate LTD in wild-type mice, i.e., the PTP, MAPK, and PI3K/ mTOR pathways (Gladding et al., 2009; Collingridge et al., 2010; Lüscher and Huber, 2010).”
BackgroundDong, C., Upadhya, S. C., Ding, L., Smith, T. K., & Hegde, A. N. (2008) · Learning & Memory · doi:10.1101/lm.984508 · Cited by 158
Niere, F., Wilkerson, J. R., & Huber, K. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4650-11.2012 · Cited by 153 · cited 1×
“FXS mice show increased Arc levels in dendrites, and lentiviral-mediated expression of FMRP in these mice normalizes both Arc levels and LTD in the hippocampus (Niere et al., 2012).”
BackgroundGiuffrida, R., Musumeci, S., D'Antoni, S., Bonaccorso, C. M., Giuffrida-Stella, A. M., Oostra, B. A., & Catania, M. V. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0932-05.2005 · Cited by 141 · cited 1×
“In FXS mice, mGlu5 receptors are less associated with the long Homer isoforms and more associated with Homer 1a (Giuffrida et al., 2005; Ronesi et al., 2012).”
BackgroundSelf-citationKelleher III, R. J., Geigenmüller, U., Hovhannisyan, H., Trautman, E., Pinard, R., Rathmell, B., Carpenter, R., & Margulies, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035003 · Cited by 116 · cited 1×
“Rare Homer 1 gene variants that potentially affect protein function cosegregate closely with autism among children of affected families (Kelleher et al., 2012).”
BackgroundThe Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc
Greer, P. L., Hanayama, R., Bloodgood, B. L., Mardinly, A. R., Lipton, D. M., Flavell, S. W., Kim, T.-K., Griffith, E. C., Waldon, Z., Maehr, R., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.026 · Cited by 30 · cited 2×
“…Ube3A micem-/p+ < 45 kDa < 49 kDa < 49 kDa β-actin > Homer 1b/c > Homer 1a > 0 50 100 150 200 250 * 1.6 1.2 0.8 0.4 280 kDa 45 kDa m-/p+ Ube3A mouse m+/p+Ube3A mouse m-/p+ * * Ube3A mice hippocampus of AS mice because Arc is a substrate for Ube3A (Greer et al., 2010).”
Influential
Cited by
Cerebral plasticity: windows of opportunity in the developing brain
Ismail, F. Y., Fatemi, A., & Johnston, M. V. (2017) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2016.07.007 · Cited by 572
Synaptopathology Involved in Autism Spectrum Disorder
Guang, S., Pang, N., Deng, X., Yang, L., He, F., Wu, L., Chen, C., Yin, F., & Peng, J. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00470 · Cited by 286
Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism
Huber, K. M., Klann, E., Costa-Mattioli, M., & Zukin, R. S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2656-15.2015 · Cited by 167
“Recent work indicates that mGluR5–Homer interactions are enhanced in the Angelman syndrome mouse model (Ube3A maternal deletion), which may contribute to impairments in mGluR-induced LTD (Pignatelli et al., 2014).”
BackgroundAutism and the synapse: emerging mechanisms and mechanism-based therapies
Ebrahimi-Fakhari, D., & Sahin, M. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000186 · Cited by 167
UBE3A Regulates Synaptic Plasticity and Learning and Memory by Controlling SK2 Channel Endocytosis
Sun, J., Zhu, G., Liu, Y., Standley, S., Ji, A., Tunuguntla, R., Wang, Y., Claus, C., Luo, Y., Baudry, M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.023 · Cited by 131
“A recent study reported that mGlu5-receptor-mediated LTD was also enhanced in AS mice (Pignatelli et al., 2014).”
Metadata
- Authors
- Pignatelli, M., Piccinin, S., Molinaro, G., Di Menna, L., Riozzi, B., Cannella, M., Motolese, M., Vetere, G., Catania, M. V., Battaglia, G., Nicoletti, F., Nisticò, R., & Bruno, V.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2014-03-26
- Volume
- 34
- Issue
- 13
- Pages
- 4558-4566
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2015084007
- Cited by
- 77
- References
- 26
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.